TREATMENT OF AMENORRHOEA WITH MENOPAUSAL URINARY GONADOTROPHIN EVALUATED BY THIN-LAYER CHROMATOGRAPHIC DETERMINATION OF PREGNANEDIOL IN THE URINE
ABSTRACT Three young amenorrhoeic hypogonadal women, aged 19-24 years, all nulliparous, with a monophasic basal-temperature curve for at least 2 months, a low hypotrophic vaginal cytology, and a constantly low pregnanediol excretion were treated with an intramuscular injection of human menopausal urinary gonadotrophin (HMG) for ten days, followed by daily injections of chorionic gonadotrophin for four days. All the patients had previously been treated unsuccessfully with chorionic gonadotrophin. The clinical effect was checked by daily thin-layer-chromatographic determination of the pregnanediol excretion in the morning urine, vaginal cytology, and daily recording of the basal temperature. Vaginal examination was done every day. One patient exhibited enlargement of the ovaries during the treatment, but apart from that there were no side effects, in particular no abnormal increase in basal temperature and no local reactions in the treated patients. All the patients developed vaginal bleeding following an increase of the pregnanediol excretion. One woman conceived.